Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses. Notably, this capability extends to targeting the COVID-19 virus, its various strains, and associated exosomes. Furthermore, Aethlon Medical maintains a collaborative partnership with the University of Pittsburgh Medical Center's Hillman Cancer Center, conducting studies pertinent to head and neck cancer. Established in 1999, the company is headquartered in San Diego, California.
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Aethlon Medical stocks are traded under the ticker EJU.MU.
What is Aethlon Medical revenue for the last year?▼
Aethlon Medical revenue for the last year amounts to 0 EUR.
What is Aethlon Medical net income for the last year?▼
EJU.MU net income for the last year is -6.11M EUR.
How many employees does Aethlon Medical have?▼
As of August 13, 2026, the company has 9 employees.
In which sector is Aethlon Medical located?▼
Aethlon Medical operates in the Health & Wellness sector.
When did Aethlon Medical complete a stock split?▼
Aethlon Medical has not had any recent stock splits.
Where is Aethlon Medical headquartered?▼
Aethlon Medical is headquartered in San Diego, United States.